Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients With Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?
Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics11110566
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 31, 2019
Authors
Publisher
MDPI AG